Clinical Trial Update: Herombopag Olamine in the Treatment of Thrombocytopenia After Chemotherapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Herombopag Olamine in treating thrombocytopenia after chemotherapy, sponsored by Huazhong University of Science and Technology…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Tumors of the Digestive System
• Thrombocytopenia

Drugs mentioned

• Herombopag Olamine (Herombopag olamine)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Malignant Tumors of the Digestive System, Trombocitopenia | Phase 4 | Status: UNKNOWN